Outcome of Surgical Management for Abdominal Aortic Pseudoaneurysm in Behçet Disease: A Shift from Open Surgery Towards Endovascular Repair

Weihao Li,Tao Zhang,Chenyang Shen
DOI: https://doi.org/10.1016/j.jvs.2015.04.430
IF: 4.86
2015-01-01
Journal of Vascular Surgery
Abstract:This study evaluated the effectiveness of open surgery and endovascular repair (EVAR) for abdominal aortic pseudoaneurysm (pseudo-AAA) in patients with Behçet disease (BD) and investigated the optimal surgical management. Between January 2003 and April 2014, 11 consecutive patients (all men) with pseudo-AAA with BD were treated in Peking University People's Hospital. All patients were required to accept immunosuppressive medication once the diagnosis of BD was confirmed. Five open surgical procedures and 11 EVARs were performed for de novo and recurrent lesions. The de novo arterial lesions comprised 8 infrarenal, 1 juxtarenal, 1 suprarenal, and 1 with multiple thoracoabdominal aortic pseudoaneurysms. In the open surgery group, three of five procedures were performed as remedial measures for recurrence of pseudo-AAA. No early operative deaths were observed. In EVAR group, 9 tubular, 1 aortouniiliac tapered, 2 aortobiiliac stents grafts, and 2 uncovered stents were used. One patient undergoing chimney technique suffered type Ia endoleak. In a median of 28 months of follow-up, the overall survival was 72.7%, and the relapse-free survival was 45.5%. Nine recurrent pseudo-AAAs were recorded in five patients, with four after open surgery (66.7%) and five after EVAR (55%). Three aneurysm-associated death were linked with recurrent pseudo-AAA after open surgery (n = 2) and challenging anatomy after EVAR (n = 1). Our initial experience suggests that EVAR is a reasonably safe and effective alternative to surgical repair for most patients and that open surgery procedures remain the effective treatment for BD patients with complicated anatomy and recurrent pseudo-AAA.
What problem does this paper attempt to address?